Helidac

Helidac is a brand name of bismuth subsalicylate/metronidazole/tetracycline, approved by the FDA in the following formulation(s):

HELIDAC (bismuth subsalicylate; metronidazole; tetracycline hydrochloride - tablet, chewable, tablet, capsule; oral)

• 
  Manufacturer: PROMETHEUS LABS
  
  Approval date: August 15, 1996
  
  Strength(s): 262.4MG,N/A,N/A;N/A,250MG,N/A;N/A,N/A,500MG ^[RLD]

Has a generic version of Helidac been approved?

No. There is currently no therapeutically equivalent version of Helidac available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Helidac. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Helidac.

See also...

• Helidac Therapy Pack Consumer Information (Wolters Kluwer)
• Helidac Consumer Information (Cerner Multum)
• Helidac Advanced Consumer Information (Micromedex)
• Bismuth Subsalicylate/Metronidazole/Tetracycline Therapy Pack Consumer Information (Wolters Kluwer)
• Bismuth subsalicylate, metronidazole, and tetracycline Consumer Information (Cerner Multum)
• Bismuth subsalicylate, metronidazole, and tetracycline Advanced Consumer Information (Micromedex)